These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36402211)

  • 1. Human cell-based estrogen receptor beta dimerization assay.
    Seo H; Seo H; Byrd N; Kim H; Lee KG; Lee SH; Park Y
    Chem Biol Interact; 2023 Jan; 369():110264. PubMed ID: 36402211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of cellular estrogen signaling in representative estrogen receptor ligands.
    Seo H; Seo H; Lee HY; Lee SH; Park Y
    Chem Biol Interact; 2023 Jan; 369():110303. PubMed ID: 36513145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermolecular interactions identify ligand-selective activity of estrogen receptor alpha/beta dimers.
    Powell E; Xu W
    Proc Natl Acad Sci U S A; 2008 Dec; 105(48):19012-7. PubMed ID: 19022902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a Human Estrogen Receptor Dimerization Assay for the Estrogenic Endocrine-Disrupting Chemicals Using Bioluminescence Resonance Energy Transfer.
    Kim HM; Seo H; Park Y; Lee HS; Lee SH; Ko KS
    Int J Environ Res Public Health; 2021 Aug; 18(16):. PubMed ID: 34444624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioassays for estrogenic activity: development and validation of estrogen receptor (ERalpha/ERbeta) and breast cancer proliferation bioassays to measure serum estrogenic activity in clinical studies.
    Li J; Lee L; Gong Y; Shen P; Wong SP; Wise SD; Yong EL
    Assay Drug Dev Technol; 2009 Feb; 7(1):80-9. PubMed ID: 19382890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a recombinant human ovarian (BG1) cell line containing estrogen receptor α and β for improved detection of estrogenic/antiestrogenic chemicals.
    Brennan JC; Bassal A; He G; Denison MS
    Environ Toxicol Chem; 2016 Jan; 35(1):91-100. PubMed ID: 26139245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of estrogen receptor alpha and ERbeta by 4-methylbenzylidene-camphor in human and rat cells: comparison with phyto- and xenoestrogens.
    Mueller SO; Kling M; Arifin Firzani P; Mecky A; Duranti E; Shields-Botella J; Delansorne R; Broschard T; Kramer PJ
    Toxicol Lett; 2003 Apr; 142(1-2):89-101. PubMed ID: 12765243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo molecular imaging of estrogen receptor α and β homo- and heterodimerization: exploration of new modes of receptor regulation.
    Paulmurugan R; Tamrazi A; Massoud TF; Katzenellenbogen JA; Gambhir SS
    Mol Endocrinol; 2011 Dec; 25(12):2029-40. PubMed ID: 22052998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An In vitro dimerization assay for the adverse outcome pathway approach in risk assessment of human estrogen receptor α-mediated endocrine-disrupting chemicals.
    Lee SH; Seo H; Seo H; Lazari M; D'Agostino M; Byrd N; Yoon KS; Lee HS; Park Y
    Chemosphere; 2022 Mar; 290():133267. PubMed ID: 34914963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Computational-Based Approach to Identify Estrogen Receptor
    Coriano CG; Liu F; Sievers CK; Liang M; Wang Y; Lim Y; Yu M; Xu W
    Mol Pharmacol; 2018 Mar; 93(3):197-207. PubMed ID: 29295894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens.
    Hall JM; McDonnell DP
    Endocrinology; 1999 Dec; 140(12):5566-78. PubMed ID: 10579320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell proliferation and modulation of interaction of estrogen receptors with coregulators induced by ERα and ERβ agonists.
    Evers NM; van den Berg JH; Wang S; Melchers D; Houtman R; de Haan LH; Ederveen AG; Groten JP; Rietjens IM
    J Steroid Biochem Mol Biol; 2014 Sep; 143():376-85. PubMed ID: 24923734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential requirements of Hsp90 and DNA for the formation of estrogen receptor homodimers and heterodimers.
    Powell E; Wang Y; Shapiro DJ; Xu W
    J Biol Chem; 2010 May; 285(21):16125-34. PubMed ID: 20353944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen receptor beta activates the human retinoic acid receptor alpha-1 promoter in response to tamoxifen and other estrogen receptor antagonists, but not in response to estrogen.
    Zou A; Marschke KB; Arnold KE; Berger EM; Fitzgerald P; Mais DE; Allegretto EA
    Mol Endocrinol; 1999 Mar; 13(3):418-30. PubMed ID: 10076999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dominant activity of activation function 1 (AF-1) and differential stoichiometric requirements for AF-1 and -2 in the estrogen receptor alpha-beta heterodimeric complex.
    Tremblay GB; Tremblay A; Labrie F; Giguère V
    Mol Cell Biol; 1999 Mar; 19(3):1919-27. PubMed ID: 10022879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of ligands with bicyclic scaffolds provides insights into mechanisms of estrogen receptor subtype selectivity.
    Hsieh RW; Rajan SS; Sharma SK; Guo Y; DeSombre ER; Mrksich M; Greene GL
    J Biol Chem; 2006 Jun; 281(26):17909-19. PubMed ID: 16648639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatty acids derived from royal jelly are modulators of estrogen receptor functions.
    Moutsatsou P; Papoutsi Z; Kassi E; Heldring N; Zhao C; Tsiapara A; Melliou E; Chrousos GP; Chinou I; Karshikoff A; Nilsson L; Dahlman-Wright K
    PLoS One; 2010 Dec; 5(12):e15594. PubMed ID: 21203528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptor-beta sensitizes breast cancer cells to the anti-estrogenic actions of endoxifen.
    Wu X; Subramaniam M; Grygo SB; Sun Z; Negron V; Lingle WL; Goetz MP; Ingle JN; Spelsberg TC; Hawse JR
    Breast Cancer Res; 2011 Mar; 13(2):R27. PubMed ID: 21392396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective activation of estrogen receptor-beta transcriptional pathways by an herbal extract.
    Cvoro A; Paruthiyil S; Jones JO; Tzagarakis-Foster C; Clegg NJ; Tatomer D; Medina RT; Tagliaferri M; Schaufele F; Scanlan TS; Diamond MI; Cohen I; Leitman DC
    Endocrinology; 2007 Feb; 148(2):538-47. PubMed ID: 17095596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of a novel estrogenic ligand actinopolymorphol A.
    Powell E; Huang SX; Xu Y; Rajski SR; Wang Y; Peters N; Guo S; Xu HE; Hoffmann FM; Shen B; Xu W
    Biochem Pharmacol; 2010 Oct; 80(8):1221-9. PubMed ID: 20599778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.